vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.

First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $16.1M, roughly 1.6× Fortress Biotech, Inc.). First Bancorp, Inc runs the higher net margin — 39.4% vs -24.5%, a 63.9% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs 6.3%). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

FBIO vs FNLC — Head-to-Head

Bigger by revenue
FNLC
FNLC
1.6× larger
FNLC
$25.8M
$16.1M
FBIO
Growing faster (revenue YoY)
FNLC
FNLC
+11.3% gap
FNLC
17.5%
6.3%
FBIO
Higher net margin
FNLC
FNLC
63.9% more per $
FNLC
39.4%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
FNLC
FNLC
Revenue
$16.1M
$25.8M
Net Profit
$-3.9M
$10.2M
Gross Margin
66.1%
Operating Margin
-28.8%
48.1%
Net Margin
-24.5%
39.4%
Revenue YoY
6.3%
17.5%
Net Profit YoY
41.8%
39.7%
EPS (diluted)
$-0.15
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
FNLC
FNLC
Q4 25
$16.1M
$25.8M
Q3 25
$17.6M
$24.5M
Q2 25
$16.4M
$22.5M
Q1 25
$13.1M
$21.8M
Q4 24
$15.1M
$22.0M
Q3 24
$14.6M
$20.5M
Q2 24
$14.9M
$19.2M
Q1 24
$13.0M
$18.5M
Net Profit
FBIO
FBIO
FNLC
FNLC
Q4 25
$-3.9M
$10.2M
Q3 25
$5.8M
$9.1M
Q2 25
$15.5M
$8.1M
Q1 25
$-10.6M
$7.1M
Q4 24
$-6.8M
$7.3M
Q3 24
$-12.9M
$7.6M
Q2 24
$-10.9M
$6.2M
Q1 24
$-15.4M
$6.0M
Gross Margin
FBIO
FBIO
FNLC
FNLC
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
FNLC
FNLC
Q4 25
-28.8%
48.1%
Q3 25
-38.6%
45.2%
Q2 25
-222.2%
43.7%
Q1 25
-169.9%
39.3%
Q4 24
-158.3%
39.5%
Q3 24
-151.0%
44.6%
Q2 24
-186.5%
38.8%
Q1 24
-280.6%
39.3%
Net Margin
FBIO
FBIO
FNLC
FNLC
Q4 25
-24.5%
39.4%
Q3 25
33.2%
37.0%
Q2 25
94.4%
35.8%
Q1 25
-80.6%
32.5%
Q4 24
-44.7%
33.1%
Q3 24
-88.0%
36.9%
Q2 24
-73.5%
32.1%
Q1 24
-118.3%
32.5%
EPS (diluted)
FBIO
FBIO
FNLC
FNLC
Q4 25
$-0.15
$0.91
Q3 25
$0.11
$0.81
Q2 25
$0.45
$0.72
Q1 25
$-0.48
$0.63
Q4 24
$-0.16
$0.66
Q3 24
$-0.76
$0.68
Q2 24
$-0.73
$0.55
Q1 24
$-1.04
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
FNLC
FNLC
Cash + ST InvestmentsLiquidity on hand
$79.4M
Total DebtLower is stronger
$52.4M
$95.5M
Stockholders' EquityBook value
$49.9M
$283.1M
Total Assets
$185.5M
$3.2B
Debt / EquityLower = less leverage
1.05×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
FNLC
FNLC
Q4 25
$79.4M
Q3 25
$86.2M
Q2 25
$74.4M
Q1 25
$91.3M
Q4 24
$57.3M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
FNLC
FNLC
Q4 25
$52.4M
$95.5M
Q3 25
$47.8M
$95.5M
Q2 25
$50.0M
$95.0M
Q1 25
$56.4M
$70.0M
Q4 24
$58.0M
$95.0M
Q3 24
$52.5M
$95.0M
Q2 24
$67.0M
$70.0M
Q1 24
$61.4M
$70.0M
Stockholders' Equity
FBIO
FBIO
FNLC
FNLC
Q4 25
$49.9M
$283.1M
Q3 25
$55.9M
$274.6M
Q2 25
$43.9M
$265.5M
Q1 25
$22.3M
$259.7M
Q4 24
$22.7M
$252.5M
Q3 24
$21.2M
$256.8M
Q2 24
$17.9M
$244.7M
Q1 24
$23.0M
$242.6M
Total Assets
FBIO
FBIO
FNLC
FNLC
Q4 25
$185.5M
$3.2B
Q3 25
$181.4M
$3.2B
Q2 25
$159.9M
$3.2B
Q1 25
$178.1M
$3.2B
Q4 24
$144.2M
$3.2B
Q3 24
$127.1M
$3.1B
Q2 24
$145.7M
$3.1B
Q1 24
$164.6M
$3.0B
Debt / Equity
FBIO
FBIO
FNLC
FNLC
Q4 25
1.05×
0.34×
Q3 25
0.86×
0.35×
Q2 25
1.14×
0.36×
Q1 25
2.53×
0.27×
Q4 24
2.55×
0.38×
Q3 24
2.48×
0.37×
Q2 24
3.75×
0.29×
Q1 24
2.67×
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
FNLC
FNLC
Operating Cash FlowLast quarter
$-12.5M
$37.8M
Free Cash FlowOCF − Capex
$34.6M
FCF MarginFCF / Revenue
133.9%
Capex IntensityCapex / Revenue
12.5%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
FNLC
FNLC
Q4 25
$-12.5M
$37.8M
Q3 25
$-6.1M
$12.9M
Q2 25
$-27.6M
$7.4M
Q1 25
$-19.6M
$2.2M
Q4 24
$-12.9M
$26.0M
Q3 24
$-20.1M
$9.8M
Q2 24
$-21.8M
$6.4M
Q1 24
$-25.4M
$-1.5M
Free Cash Flow
FBIO
FBIO
FNLC
FNLC
Q4 25
$34.6M
Q3 25
$12.6M
Q2 25
$7.2M
Q1 25
$828.0K
Q4 24
$24.6M
Q3 24
$9.6M
Q2 24
$6.3M
Q1 24
$-1.8M
FCF Margin
FBIO
FBIO
FNLC
FNLC
Q4 25
133.9%
Q3 25
51.4%
Q2 25
32.1%
Q1 25
3.8%
Q4 24
111.7%
Q3 24
47.0%
Q2 24
32.9%
Q1 24
-9.8%
Capex Intensity
FBIO
FBIO
FNLC
FNLC
Q4 25
12.5%
Q3 25
1.2%
Q2 25
0.6%
Q1 25
6.2%
Q4 24
6.7%
Q3 24
0.0%
0.5%
Q2 24
0.3%
Q1 24
1.8%
Cash Conversion
FBIO
FBIO
FNLC
FNLC
Q4 25
3.72×
Q3 25
-1.04×
1.42×
Q2 25
-1.78×
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons